Effect of therapy with deflazacort on dyslipoproteinemia after pediatric renal transplantation

Journal of Pediatrics

Volumn 133, Issue 4, 1998, Pages 533-536

  Ferraris, J R ^a   Sorroche, P ^a   Legal, S ^a   Oyhamburu, J ^a   Brandi, P ^a   Pasqualini, T ^a  

^a NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CYCLOSPORIN; DEFLAZACORT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CREATININE CLEARANCE; DRUG EFFECT; DYSLIPOPROTEINEMIA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031715603     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(98)70063-0     Document Type: Article

References (38)

1. BL Kasiske AJ Umen Persistent hyperlipidemia in renal transplant patients Medicine 66 1987 309 316
2. H Isoniemi M Tikkanen P Häyry B Eklund K Höeckerstedt K Salmela Lipid profiles with triple drug immunosuppressive therapy and with double combinations after renal transplantation and stable graft function Transplant Proc 23 1991 1029 1031
3. LS Ibels JH Stewart JF Mahony FC Neale AGR Sheil Occlusive arterial disease in uremic and hemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of atherosclerosis Q J Med 46 1977 197 214
4. TB Drüeke Z Abdulmassih B Lacour C Bader A Chevalier H Kreis Atherosclerosis and lipid disorders after renal transplantation Kidney Int 39 suppl 31 1991 S24 S28
5. FP Brunner M Broyer H Brynger S Challah SR Dykes W Fassbinder Survival on renal replacement therapy: data from the EDTA registry Nephrol Dial Transplant 2 1988 109 122
6. ML Foegh Chronic rejection: graft atherosclerosis Transplant Proc 22 1990 119 122
7. J Nichols AM Cumming GRD Catto N Edward J Engeset Lipid relationship in dialysis and renal transplant patients Q J Med 198 1981 149 160
8. DC Cattran G Steiner DR Wilson SSA Fenton Hyperlipemia after renal transplantation: natural history and pathophysiology Ann Intern Med 91 1979 554 559
9. AEG Raine PJ Morris Hyperlipidemia after renal transplantation [abstract] Lancet 2 1988 391
10. G Nathanson G Winters E Testa Steroids possessing nitrogen atoms. III. Synthesis of new highly active corticoids: [17-Alpha, 16-Alpha-d] oxazolino steroids J Med Chem 10 1967 799 802
11. S Balsan D Stéru A Bourdeau R Grimberg G Lenoir Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth Calcif Tissue Int 40 1987 303 309
12. G Pagano A Bruno P Cavallo-Perin L Cesco B Imbimbo Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone Arch Intern Med 149 1989 1098 1101
13. B Hahn S Pletscher M Munian Immunosuppressive effects of deflazacort: a new glucocorticoid with bone-sparing and carbohydrate-sparing properties-comparison with prednisone J Rheumatol 8 1981 783 790
14. J Ferraris P Fainstein Day R Gutman E Granillo J Ramirez S Ruiz Effect of therapy with a new glucocorticoid, deflazacort, on linear growth and growth hormone secretion after renal transplantation J Pediatr 121 1992 809 813
15. JR Ferraris P Pennisi T Pasqualini H Jasper Effects of deflazacort immunosuppression on long-term growth and growth factors after renal transplantation Pediatr Nephrol 11 1997 322 324
16. JR Ferraris ML Tambutti M Redal J Ramirez MC Carlin MC Samaniego Immunosuppressive activity of deflazacort in pediatric renal transplantation Transplantation 62 1996 417 420
17. A Elli R Rivolta FQ Di Palo M Parenti G Vergallo P Palazzi A randomized trial of deflazacort versus 6-methylprednisolone in renal transplantation-immunosuppressive activity and side effects Transplantation 55 1993 209 212
18. A Assandri G Buniva E Martinelli A Perazzi L Zerilli Pharmacokinetics and metabolism of deflazacort in the rat, dog, monkey and man Adv Exp Med Biol 171 1984 9 23
19. H Lejarraga CD Anigstein A Candia J Heinrich S Krupitzky O Machado Criterios de diagnóstico y tratamiento: crecimiento y desarrollo 1986 Sociedad Argentina de Pediatría, Secretaria de Publicaciones y Biblioteca Buenos Aires 3 57
20. MF Lopez-Virella P Stone S Ellis JA Colwell Cholesterol determination in high-density lipoproteins separated by three different methods Clin Chem 23 1977 882 884
21. WT Friedewald RI Levy DS Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem 18 1977 499 502
22. J Zimmerman M Fainaru S Eisenberg The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study Metabolism 33 1984 521 526
23. LS Ibels AC Alfrey R Weil III Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients Am J Med 64 1978 634 642
24. A Vathsala RB Weinberg L Schoenberg J Grewel RH Goldstein CT Van Buren Lipid abnormalities in cyclosporine-prednisone treated renal transplant recipients Transplantation 48 1989 37 43
25. RP Lowry G Soltys R Mangel P Kwiterovitch AD Sniderman Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation Transplant Proc 19 1987 2229 2232
26. JJ Curtis JH Galla SY Woodford BA Lucas RG Luke Effect of alternate-day prednisone on plasma lipids in renal transplant recipients Kidney Int 22 1982 42 47
27. DG Renlund MR Bristow BG Grandall NA Burton DB Doty SV Karwande Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression J Heart Transplant 8 1989 214 220
28. DE Hricik MR Bartucci JT Mayes JA Schulak The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients Transplantation 54 1992 868 871
29. A Tejani H Botkm D Tajpoot R Gonzalez N Buyan A Pomrantz Strategies of optimizing growth in children with kidney transplants Transplantation 47 1989 229 233
30. L Reisman KV Lieberman H Burrows H Schanzer Follow up of cyclosporine-treated pediatric renal allograft after cessation of prednisone Transplantation 49 1990 76 80
31. E Reaven OG Kolterman GM Reaven Ultrastructural and physiological evidence for corticosteroid-induced alterations in hepatic production of very low density lipoprotein particles J Lipid Res 15 1974 74 83
32. MP Stern OG Kolterman JF Fries HO McDevitt GM Reaven Adrenocortical steroid treatment of rheumatic diseases: effects on lipid metabolism Arch Intern Med 132 1973 97 101
33. I Kruse H Bar-on E Shaffir Origin and pattern of glucocorticoid-induced hyperlipidemia in rats Biochim Biophys Acta 663 1981 69 82
34. WH Ettinger HK Klinefelter P Kwiterovitch Effect of low-dose, short-term prednisone on plasma lipids Atherosclerosis 63 1987 167 172
35. LJ Hirsch T Mazzone Dexamethasone-modulated lipoprotein metabolism in cultured human monocyte-derived macrophages: stimulation of scavenger receptor activity J Clin Invest 77 1986 485 490
36. JD Bagdade D Porte EL Bierman Steroid-induced lipemia Arch Intern Med 125 1970 134 136
37. G Pagano A Lomardi GM Ferraris B Imbimbo P Cavallo-Perin Acute effect of prednisone and deflazacort on glucose tolerance in prediabetic subjects Eur J Clin Pharmacol 22 1982 469 471
38. A Bruno P Cavallo-Perin M Cassader G Pagano Deflazacort vs prednisone: effect on blood glucose control in insulin-treated diabetics Arch Intern Med 147 1987 679 680